XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Redeemable Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2014     3,317,728      
Beginning balance at Dec. 31, 2014   $ 74,319,224 $ 84,855,693 $ (12,566,133) $ 2,029,664  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative-effect adjustment from the adoption of ASU 2015-02 (Note 2) $ 0          
Issuance of restricted stock grants (shares)     73,000      
Issuance of restricted stock grants   0 $ 10,341,320 (10,341,320)    
Amortization of restricted stock grants   3,309,999   3,309,999    
Issuance of stock grants (shares)     27,192      
Issuance of stock grants 3,826,458 3,826,458 $ 3,826,458      
Issuance of common stock related to 401k plan match (shares)     4,815      
Issuance of common stock related to 401k plan match   764,437 $ 764,437      
Net excess tax benefit from vested restricted stock grants   1,619,727 $ 1,619,727      
Shares withheld related to employee tax withholding (shares)     (23,063)      
Shares withheld related to employee tax withholding   (3,235,603) $ (3,235,603)      
Forfeiture of restricted stock grants (shares)     (3,500)      
Forfeiture of restricted stock grants   0 $ (272,335) 272,335    
Net Income $ 18,690,744 18,690,744     18,690,744  
Ending balance (shares) at Jun. 30, 2015     3,396,172      
Ending balance at Jun. 30, 2015   99,294,986 $ 97,899,697 (19,325,119) 20,720,408  
Beginning balance (shares) at Dec. 31, 2015 3,414,338   3,414,338      
Beginning balance at Dec. 31, 2015   105,314,014 $ 102,536,527 (19,294,784) 22,072,271  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative-effect adjustment from the adoption of ASU 2015-02 (Note 2) $ 4,031,756         $ 4,031,756
Issuance of restricted stock grants (shares)     33,600      
Issuance of restricted stock grants   0 $ 6,699,184 (6,699,184)    
Amortization of restricted stock grants   3,235,146   3,235,146    
Issuance of stock grants (shares)     21,940      
Issuance of stock grants 3,879,431 3,879,431 $ 3,879,431      
Issuance of common stock related to 401k plan match (shares)     5,276      
Issuance of common stock related to 401k plan match   935,210 $ 935,210      
Tax benefit from dividend payments related to restricted stock grants   925,000 925,000      
Net excess tax benefit from vested restricted stock grants   4,421,408 $ 4,421,408      
Shares withheld related to employee tax withholding (shares)     (48,165)      
Shares withheld related to employee tax withholding   (9,075,447) $ (9,075,447)      
Forfeiture of restricted stock grants (shares)     (1,600)      
Forfeiture of restricted stock grants   0 $ (205,939) 205,939    
Net Income $ 19,046,986 18,980,215     18,980,215 66,771
Net issuance of ETF shares to noncontrolling shareholders           1,646,859
Ending balance (shares) at Jun. 30, 2016 3,425,389   3,425,389      
Ending balance at Jun. 30, 2016   $ 128,614,977 $ 110,115,374 $ (22,552,883) $ 41,052,486 $ 5,745,386